Variant report
Variant | esv3396561 |
---|---|
Chromosome Location | chr22:31413377-31415925 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:31413340..31416231-chr22:31418212..31420315,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs199996961 | chr22:31413444-31413445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4820925 | chr22:31413480-31413481 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs191941573 | chr22:31413526-31413527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs117684023 | chr22:31413545-31413546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183748984 | chr22:31413546-31413547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148142529 | chr22:31413568-31413569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145255966 | chr22:31413591-31413592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs5753426 | chr22:31413639-31413640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563624735 | chr22:31413738-31413739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532778845 | chr22:31413795-31413796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546037821 | chr22:31413804-31413805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559997034 | chr22:31413845-31413846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528731452 | chr22:31413853-31413854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547003190 | chr22:31413880-31413881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566957823 | chr22:31413904-31413905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9609188 | chr22:31413966-31413967 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs186642093 | chr22:31413994-31413995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192722239 | chr22:31414036-31414037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185452782 | chr22:31414039-31414040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558440755 | chr22:31414076-31414077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs377439911 | chr22:31414077-31414078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4820926 | chr22:31414089-31414090 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs534952780 | chr22:31414092-31414093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554884686 | chr22:31414094-31414095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201023447 | chr22:31414110-31414111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190704533 | chr22:31414119-31414120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543439956 | chr22:31414174-31414175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557434264 | chr22:31414188-31414189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577218582 | chr22:31414198-31414199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142246211 | chr22:31414199-31414200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs559485944 | chr22:31414215-31414216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147764509 | chr22:31414222-31414223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573084919 | chr22:31414316-31414317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542144826 | chr22:31414332-31414333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181640484 | chr22:31414412-31414413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs202236209 | chr22:31414444-31414445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370003456 | chr22:31414446-31414447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs201084515 | chr22:31414447-31414448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1859916 | chr22:31414448-31414449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs57581226 | chr22:31414450-31414451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529650937 | chr22:31414466-31414467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs8137287 | chr22:31414468-31414469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs377231264 | chr22:31414470-31414471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565640294 | chr22:31414487-31414488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs2413006 | chr22:31414488-31414489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2413007 | chr22:31414490-31414491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs202051648 | chr22:31414494-31414495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372429148 | chr22:31414507-31414508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200238450 | chr22:31414525-31414526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369032465 | chr22:31414530-31414531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 21183584 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 19521646 | CNVD |
Schizophrenia | 18990708 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Autism | 17322880 | CNVD |
Breast cancer | 20409316 | CNVD |
Neurofibromatosis type 2 | 19566914 | CNVD |
Autism | 19384346 | CNVD |
Myelofibrosis | 22110671 | CNVD |
muscular dystrophy type 1D | 21248746 | CNVD |
Leukoplakia | 24403051 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Amyotrophic lateral sclerosis | 20858604 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 17142309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:31413000-31413400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr22:31413400-31415000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr22:31415000-31416000 | Enhancers | Esophagus | oesophagus |
4 | chr22:31415000-31416600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr22:31415000-31416600 | Enhancers | Placenta | Placenta |
6 | chr22:31415200-31417200 | Enhancers | HepG2 | liver |
7 | chr22:31415600-31415800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr22:31415600-31416600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |